Latest Onyx Biotec stock price
Onyx Biotec P/E Ratio
ONYX • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
12.38
Low Valuation
Low - May indicate good value opportunity
Current Valuation Metrics
P/E Ratio
12.38
Current Price
₹
EPS (TTM)
₹3.31
Exchange
None
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
47.99
Sector Median
26.65
Sector Rank
#11 of 139
Sector Percentile
7.9%
Key P/E Ratio Insights for Onyx Biotec
- Stock appears undervalued with PE of 12.38, suggesting potential buying opportunity
- Trading at discount to sector average PE of 47.99
View the ONYX equity price for detailed stock performance.
Related Pages for Onyx Biotec
Additional stock information and data for ONYX
Sector P/E Ratio Comparison
Comparing Onyx Biotec with other companies in Healthcare sector
Sector Average
47.99
Sector Median
26.65
Lowest P/E
0.97
Highest P/E
865.71
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 3.0 | ₹43 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.74 | ₹2,188 | Low |
| Brooks Laboratories | BROOKS | 8.01 | ₹184 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |